Tango Therapeutics, Inc. — All Filings
360 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
4/A
424B3
424B4
424B5
425
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFR14A
EFFECT
FWP
POS AM
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | 4 | 0001193125-26-129990 | Mar 27, 2026 | Mar 25, 2026 |
| SCHEDULE 13G/A | — | 0000102909-26-002402 | Mar 27, 2026 | — |
| 144 | — | 0001950047-26-002998 | Mar 25, 2026 | — |
| 4 | 4 | 0001193125-26-098443 | Mar 9, 2026 | Mar 5, 2026 |
| 144 | — | 0001950047-26-002280 | Mar 5, 2026 | — |
| S-8 | S-8 | 0001193125-26-092568 | Mar 5, 2026 | — |
| 8-K | 8-K | 0001193125-26-092535 | Mar 5, 2026 | — |
| 10-K | 10-K | 0001193125-26-092518 | Mar 5, 2026 | Dec 31, 2025 |
| 4 | 4 | 0001193125-26-083579 | Feb 27, 2026 | Feb 25, 2026 |
| 144 | — | 0001950047-26-001787 | Feb 25, 2026 | — |
| SCHEDULE 13G/A | — | 0000935836-26-000119 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001193125-26-054743 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0000902664-26-001066 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0002005369-26-000012 | Feb 13, 2026 | — |
| SCHEDULE 13G | — | 0000902664-26-000912 | Feb 12, 2026 | — |
| SCHEDULE 13D/A | — | 0001193125-26-044719 | Feb 10, 2026 | — |
| SCHEDULE 13G/A | — | 0000908834-26-000056 | Feb 6, 2026 | — |
| 4 | 4 | 0001193125-26-038072 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | 4 | 0001193125-26-038070 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | 4 | 0001193125-26-038052 | Feb 4, 2026 | Feb 2, 2026 |
| SCHEDULE 13G | — | 0000102909-26-000267 | Jan 30, 2026 | — |
| SCHEDULE 13G | — | 0002012383-26-000726 | Jan 21, 2026 | — |
| 4 | 4 | 0001193125-26-009663 | Jan 12, 2026 | Jan 8, 2026 |
| 8-K | 8-K | 0001193125-26-007086 | Jan 8, 2026 | Jan 7, 2026 |
| 4 | 4 | 0001193125-26-004433 | Jan 6, 2026 | Jan 2, 2026 |
| 3 | 3 | 0001193125-26-004401 | Jan 6, 2026 | Jan 2, 2026 |
| 8-K | 8-K | 0001193125-26-001495 | Jan 5, 2026 | Jan 2, 2026 |
| EFFECT | — | 9999999995-25-003637 | Dec 10, 2025 | — |
| SCHEDULE 13D/A | — | 0001193125-25-291391 | Nov 21, 2025 | — |
| 8-K | 8-K | 0001193125-25-290679 | Nov 21, 2025 | Nov 18, 2025 |
| S-3ASR | S-3ASR | 0001193125-25-290677 | Nov 21, 2025 | — |
| S-3 | S-3 | 0001193125-25-290673 | Nov 21, 2025 | — |
| SCHEDULE 13G/A | — | 0001193125-25-283070 | Nov 14, 2025 | — |
| SCHEDULE 13D/A | — | 0001193125-25-282980 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-004875 | Nov 13, 2025 | — |
| SCHEDULE 13G/A | — | 0000908834-25-000328 | Nov 12, 2025 | — |
| 4 | 4 | 0001193125-25-263710 | Nov 4, 2025 | Nov 3, 2025 |
| 8-K | 8-K | 0001193125-25-263684 | Nov 4, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-263680 | Nov 4, 2025 | Sep 30, 2025 |
| D | — | 0001819133-25-000003 | Oct 28, 2025 | — |
| 4 | 4 | 0001193125-25-251606 | Oct 27, 2025 | Oct 23, 2025 |
| 8-K | 8-K | 0001193125-25-249302 | Oct 24, 2025 | Oct 23, 2025 |
| 424B5 | 424B5 | 0001193125-25-249286 | Oct 24, 2025 | — |
| 144 | — | 0001178937-25-000050 | Oct 23, 2025 | — |
| FWP | FWP | 0001193125-25-247690 | Oct 23, 2025 | — |
| 8-K | 8-K | 0001193125-25-247658 | Oct 23, 2025 | — |
| 4 | 4 | 0001193125-25-223227 | Sep 29, 2025 | Sep 25, 2025 |
| 144 | — | 0001178937-25-000039 | Sep 25, 2025 | — |
| SCHEDULE 13G | — | 0002005369-25-000050 | Sep 22, 2025 | — |
| 4 | 4 | 0001193125-25-206453 | Sep 17, 2025 | Sep 16, 2025 |